Featured News
525Wire StoriesWith 7 In 10 SMEs Wanting To Get Access To Financial Services From Non-Banking Platforms, ANEXT Bank Welcomes Three New Partners To Scale Access Through Embedded Financial Solutions
The ANEXT Programme for Industry Specialists aims to enable greater access to financial services for more than one million SMEs within the...
- 585News
Local Brokerage Phillip Nova Breaks New Ground with Multi-Asset Platform
Phillip Nova launches a brand-new platform Phillip Nova 2.0, claiming that is the Only One trading account investors will need. SINGAPORE –...
- 513Wire Stories
Mitsubishi Electric to Issue Green Bonds for First Time
Aiming to finance increased production of SiC power semiconductors to support decarbonization TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will...
- 574Wire Stories
Paris Agreement Article 6 Implementation Partnership (A6IP) Center is now fully operational and ready to support capacity building implementation of Article 6
TOKYO–(BUSINESS WIRE)–#A6IPCenter–The Institute for Global Environmental Strategies (IGES) is proud to announce the start of operations for the “Paris Agreement Article 6...
- 571News
EVTEKER Electric Motorcycles Shine in Milan, Highlighting the Deep Integration of Chinese-German Technologies at the Exhibition
MILAN, ITALY – Media OutReach – 10 November 2023 – On November 8th at 1:40 PM (8:40 PM Beijing time), during the...
- 518News
inQubi Launches “The New Breed Of Virtual Pets” in Asia, with Global Expansion Plans
Free App Unlocks Engaging, Exciting Gameplay For All Ages KUALA LUMPUR, MALAYSIA – Media OutReach – 10 November 2023 – Driven by...
- 549News
The Next Evolution of Blockchain Hybrid Infrastructure THXNET. Launches its Main-net To Support Its Web3-as-a-Service Offerings.
TOKYO, JAPAN – Media OutReach – 10 November 2023 – In a major leap for the digital age, THXLAB proudly announces the...
- 547Wire Stories
Sirius Therapeutics Announces Submission to Begin First Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
SAN DIEGO & SHANGHAI–(BUSINESS WIRE)–Sirius Therapeutics today announced it has submitted an application in Australia to begin a first-in-human clinical trial of...
- 608Wire Stories
BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates
Generated total revenue of $781 million and global product sales of $595 million, a 102% and 70% increase from the prior-year period,...
- 610Wire Stories
Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms Takeda Continues 70-plus Year Legacy of...
- 604Wire Stories
Bakkt Announces Expansion of International Footprint and Custody Client Base
The company expects to be live with crypto capabilities across new Latin American, European and Asian markets by year end ALPHARETTA, Ga.–(BUSINESS...
